AesthetiCare
AesthetiCare is the UK clinic development arm of Ferndale Pharmaceuticals Ltd, acting as the exclusive UK partner for Cantabria Labs, distributing ALLSKIN | MED, Heliocare 360°, and Biretix medical-grade skincare exclusively to medical aesthetic clinics, supported by a partner Academy and ticketed CPD-accredited masterclasses.
- Company typePrivate
- Founded2003
- HeadquartersWest Burton, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingServices
What AesthetiCare does
AesthetiCare is the clinic development division of Ferndale Pharmaceuticals Ltd, a UK dermatology company established in 2003 and part of the privately held Ferndale Pharma Group. It operates as the exclusive UK partner for the Cantabria Labs (Spain) dermatological skincare portfolio, distributing and supporting three core ranges exclusively to medical aesthetic clinics: ALLSKIN | MED (a clinic-exclusive, medical-grade skin, hair and scalp range built on patented growth factor technology and designed to work synergistically with in-clinic treatments), Heliocare 360° (an award-winning full-spectrum sun protection range built on patented Fernblock and ASPA-Fernblock technologies covering UVA, UVB, visible light and infrared-A), and Biretix (an acne-targeted range using patented RetinSphere dual-release retinol and BIOPEP-15 antimicrobial peptide technology). Product sales flow exclusively through verified clinic partners via the shop.aestheticare.co.uk professional storefront, with the company providing parallel value through a digital Academy training hub, structured CPD-accredited masterclasses (including the ALLSKIN | MED Discovery Event Series 2026 and the Mastering Regenerative Haircare masterclass series), bespoke marketing toolkits, and account management.
The business model is B2B wholesale distribution combined with recurring partner-services revenue. Clinics purchase products through a verified-partner wholesale relationship that is unavailable to general consumers, particularly for the ALLSKIN | MED line which is clinic-exclusive. AesthetiCare monetises the relationship beyond product supply via the Academy subscription-style partner support platform and ticketed training events (Discovery Events at £50–£55+VAT and the Regenerative Haircare masterclass at £85+VAT, both bundling complimentary ALLSKIN | MED skincare regimes). Pricing for clinic product purchases is not publicly disclosed and requires partnership onboarding; in 2026 the company announced a pricing update ending a three-year ALLSKIN | MED price freeze and a 20% reduction in Heliocare 360° UK trade and in-clinic recommended retail prices. The company is headquartered in Wetherby, West Yorkshire, employs 11–50 staff, and serves the United Kingdom market only, having maintained the Cantabria Labs exclusive distribution relationship for over 14 years.
AesthetiCare firmographics
Firmographics- Name
- AesthetiCare
- Legal name
- Ferndale Pharmaceuticals Limited
- Website
- https://aestheticare.co.uk
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- AesthetiCare is the UK clinic development arm of Ferndale Pharmaceuticals Ltd, acting as the exclusive UK partner for Cantabria Labs, distributing ALLSKIN | MED, Heliocare 360°, and Biretix medical-grade skincare exclusively to medical aesthetic clinics, supported by a partner Academy and ticketed CPD-accredited masterclasses.
- Ownership category
- akta.pro rank
AesthetiCare industry classification
Industry- Product category
- Professional Medical-Grade Skincare Distribution
- NAICS
- Health and Personal Care Retailers (456)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Perfumes, Cosmetics & Other Toilet Preparations (2844)
- akta.pro primary industry
- Dermocosmetics & Medical-Grade Skincare (CRABAAAF)
- akta.pro secondary industries
- Professional/Backbar Skincare (Esthetician & Spa Use) (CRABAAAK), Medical-Grade / Clinical Facials (Dermatology & Med Spa) (HSALADAN)
Keywords
Where AesthetiCare is headquartered
LocationHeadquarters
- HQ city
- West Burton
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
AesthetiCare business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Supply Chain
Revenue model
- Medical-grade skincare product sales: AesthetiCare generates revenue through the sale of medical-grade dermatological skincare products — ALLSKIN | MED, Heliocare 360°, and Biretix — exclusively to aesthetic skin clinic partners. Clinics purchase products as a wholesale/b2b relationship and resell to end consumers. Products are available through a professional shop at shop.aestheticare.co.uk, accessible to verified clinic partners.
- Partnership services and academy access: AesthetiCare provides a digital Academy hub to partner clinics offering training, masterclasses, marketing toolkits, and business development resources as part of the partnership programme. The Academy is an exclusive partner support platform accessible upon clinic partnership enrollment.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Mastering Regenerative Haircare masterclass tickets (London) |
| Unit Pricing | Pay-as-you-go | ALLSKIN | MED Discovery Event Series 2026 tickets |
| Unit Pricing | Pay-as-you-go | ALLSKIN | MED Business Event: Scaling Success in Aesthetic Practice |
| Other | Monthly | Clinic product pricing (ALLSKIN | MED, Heliocare 360°, Biretix) |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
AesthetiCare product offering
Product offeringCore offering
AesthetiCare functions as the clinic development arm of Ferndale Pharmaceuticals Ltd, distributing three medical-grade dermatological skincare ranges from Cantabria Labs — ALLSKIN | MED, Heliocare 360° and Biretix — exclusively to medical aesthetic skin clinics across the United Kingdom. The offering is complemented by clinic-facing services including a training academy, marketing support and field-based account management.
Product overview
AesthetiCare, operating as a division of Ferndale Pharmaceuticals Ltd, offers a portfolio of professional dermo-cosmetic skincare brands exclusively for aesthetic clinics. The portfolio comprises three core product ranges: ALLSKIN | MED (a clinic-exclusive medical-grade skin, hair, and scalp range from Cantabria Labs with patented growth factor technology), Heliocare 360° (an award-winning sun protection range featuring patented Fernblock technology for broad-spectrum UV and environmental protection), and Biretix (a clinically proven skincare range for oily and spot-prone skin using RetinSphere® and BIOPEP-15 technologies). These products are designed to work in synergy with professional aesthetic treatments, providing holistic skincare solutions across anti-ageing, pigmentation, acne, and sun protection categories.
Differentiator
Problem solved
Functional benefit
Brands
- ALLSKIN | MED: Clinic-exclusive, medical-grade skin, hair, and scalp range from Cantabria Labs designed to work in partnership with advanced treatments, enhancing outcomes and reducing downtime
- Heliocare 360°
- Biretix
Products and services
- ALLSKIN | MED
Quantifiable outcome
- Biretix significantly reduces blemishes in 30 days
- +3 more outcomes
Companies that use AesthetiCare
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles1 record
AesthetiCare technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
Feature6 records
AesthetiCare partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered flagship and minor.
- Cantabria LabsflagshipFerndale Pharma (and therefore AesthetiCare) is the exclusive UK partner for the Cantabria Labs dermatological skincare portfolio. Cantabria Labs is a leading international dermatology company dedicated to dermatological research and innovation. This exclusive partnership has been in place for over 14 years, covering the ALLSKIN | MED (clinic-exclusive medical-grade skincare), Heliocare 360° (advanced sun protection), and Biretix (acne skincare) ranges developed by Cantabria Labs and distributed in the UK through AesthetiCare.
- Hope For JusticeminorAesthetiCare follows guidelines and advice provided by Hope For Justice, a charity working to end modern slavery, to train staff in spotting potential signs of modern slavery and human trafficking within their operations and supply chain. This is part of AesthetiCare's Modern Slavery Act compliance policy.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
AesthetiCare competitors and assessment
Company assessmentDirect peers
- Medik8: UK-based cosmeceutical brand distributing professional-grade skincare (vitamin C, retinoid, and acid ranges) through clinics and skin specialists. Directly comparable to AesthetiCare as a clinic-channel, medical-grade skincare portfolio targeting aesthetic professionals in the UK.
- SkinCeuticals: L'Oréal-owned medical-grade skincare brand with a clinic-exclusive distribution model and patented L-ascorbic acid (CE Ferulic) and other professional technologies. Closest large-scale analog to AesthetiCare's ALLSKIN | MED model of clinic-exclusive, science-backed skincare dispensed by aesthetic professionals.
- ZO Skin Health: Medical-grade skincare brand founded by Zein Obagi, sold exclusively through physician channels and clinics globally. Comparable to AesthetiCare as a clinic-dispensed, professional-only, results-driven skincare line built on patented protocols and active ingredients.
- AlumierMD: Canadian-origin professional skincare brand distributed exclusively through medical aesthetic clinics and skin specialists. Directly competes with AesthetiCare's clinic-exclusive model, offering comparable medical-grade product ranges with dedicated training and marketing partner support.
- PCA Skin: Professional skincare brand sold exclusively through licensed skin care professionals and medical practices. Comparable as a clinic-channel-only medical-grade skincare line with chemical peels and active-ingredient regimens aimed at aesthetic professionals.
- Obagi Medical: Medical-grade skincare brand sold through physicians, med-spas and aesthetic clinics (now part of Valeant/Bausch Health). Comparable to AesthetiCare as a clinician-dispensed portfolio addressing hyperpigmentation, ageing and acne with proprietary formulations.
Emerging players
- iS Clinical: Professional skincare line distributed through skincare professionals, spas and medical practices with a clinically-driven positioning. Comparable niche overlap with AesthetiCare's clinic-only medical-grade model, particularly around post-procedure and cancer-care skincare.
- Environ Skin Care: Professional skincare brand based on vitamin A step-up system, sold through approved skin care therapists and clinics globally. Similar professional-only channel and science-led, results-oriented positioning to AesthetiCare's ALLSKIN | MED range.
- Revision Skincare: Professional skincare brand distributed exclusively through physicians and licensed skincare providers. Comparable in targeting aesthetic clinics with clinically-validated, medical-grade formulations focused on ageing and skin health.
- Neostrata: Professional skincare brand pioneering glycolic acid and polyhydroxy acid technology, sold through dermatologists, physicians and skin care professionals. Comparable as a science-led, clinic-channel skincare franchise with patented active-ingredient technology.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
AesthetiCare social profiles
Digital presenceAesthetiCare compliance and trust
Trust signalCompliance1 record
AesthetiCare financial estimates
Financial estimateRevenue estimate
Valuation estimate
AesthetiCare leadership team
Management profileNumber of profiles
Profiles2 records
AesthetiCare funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AesthetiCare M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AesthetiCare
What does AesthetiCare do?
AesthetiCare functions as the clinic development arm of Ferndale Pharmaceuticals Ltd, distributing three medical-grade dermatological skincare ranges from Cantabria Labs — ALLSKIN | MED, Heliocare 360° and Biretix — exclusively to medical aesthetic skin clinics across the United Kingdom. The offering is complemented by clinic-facing services including a training academy, marketing support and field-based account management.
Is AesthetiCare a public or private company?
AesthetiCare is a private company. It is classified as corporate owned and is currently operating.
When was AesthetiCare founded?
AesthetiCare was founded in 2003. It employs 11 to 50 people.
Where is AesthetiCare based?
AesthetiCare is headquartered in West Burton, United Kingdom, in the Europe region.
How does AesthetiCare make money?
Two revenue lines are on record. Medical-grade skincare product sales are the primary driver. The others are partnership services and academy access.
Who are AesthetiCare's main competitors?
Direct peers on record are Medik8, SkinCeuticals, ZO Skin Health, AlumierMD, PCA Skin and Obagi Medical. Emerging players are iS Clinical, Environ Skin Care, Revision Skincare and Neostrata.
Does AesthetiCare have an API?
No public API is recorded for AesthetiCare.
What industry is AesthetiCare in?
AesthetiCare's product category is Professional Medical-Grade Skincare Distribution. Its primary akta.pro industry code is CRABAAAF, Dermocosmetics & Medical-Grade Skincare, with a secondary code of CRABAAAK, Professional/Backbar Skincare (Esthetician & Spa Use). Its NAICS code is 456 and its SIC code is 5122.